Glutathione IV therapy is a treatment that involves the intravenous administration of glutathione, a powerful antioxidant produced naturally by the body
(2008), actively dividing cells such as bone marrow are susceptible to T-2 toxin, including the tibial growth plates, which regulate chondrocyte formation, maturation, and turnover
Blood cell production typically begins improving within 35 days, haemoglobin rises over 12 months, whilst neurological recovery may take several months
So trial design is a big, big issue. However, he is optimistic that HER-096 will eschew some of the pitfalls of other drug candidates
This approach significantly reduces P-gp expression and inhibits the IL-6/pSTAT3 inflammatory pathway, thereby reversing resistance in the TME